HOXA9 inhibits HIF-1α-mediated glycolysis through interacting with CRIP2 to repress cutaneous squamous cell carcinoma development.
about
HOXA9 inhibits HIF-1α-mediated glycolysis through interacting with CRIP2 to repress cutaneous squamous cell carcinoma development.
description
2018 nî lūn-bûn
@nan
2018年の論文
@ja
2018年学术文章
@wuu
2018年学术文章
@zh
2018年学术文章
@zh-cn
2018年学术文章
@zh-hans
2018年学术文章
@zh-my
2018年学术文章
@zh-sg
2018年學術文章
@yue
2018年學術文章
@zh-hant
name
HOXA9 inhibits HIF-1α-mediated ...... us cell carcinoma development.
@en
HOXA9 inhibits HIF-1α-mediated ...... us cell carcinoma development.
@nl
type
label
HOXA9 inhibits HIF-1α-mediated ...... us cell carcinoma development.
@en
HOXA9 inhibits HIF-1α-mediated ...... us cell carcinoma development.
@nl
prefLabel
HOXA9 inhibits HIF-1α-mediated ...... us cell carcinoma development.
@en
HOXA9 inhibits HIF-1α-mediated ...... us cell carcinoma development.
@nl
P2093
P2860
P50
P1476
HOXA9 inhibits HIF-1α-mediated ...... ous cell carcinoma development
@en
P2093
Meijuan Zhou
Pengfei Wang
Ying Zhang
Yinghui Wang
P2860
P2888
P356
10.1038/S41467-018-03914-5
P407
P577
2018-04-16T00:00:00Z